论文部分内容阅读
目的:探讨米非司酮联合甲氨蝶呤保守治疗宫外孕的疗效分析。方法:选取我院2016年1月至2017年1月收治的宫外孕患者80例,采用动态化随机单双号的方式进行分组,对照组患者40例,采用甲氨蝶呤进行治疗,观察组患者40例,采用米非司酮联合甲氨蝶呤进行治疗,对比两组患者治疗效果以及不良反应发生情况。结果:观察组治疗效果为95.00%,对照组治疗效果为75.00%,观察组治疗效果明显高于对照组,两组对比有显著差异(P小于0.05);观察组患者不良反应发生率与对照组相同,都为12.50%,两组对比无显著差异(P大于0.05)。结论:米非司酮联合甲氨蝶呤可以有效治疗宫外孕,在临床上有一定的应用价值,值得推广。
Objective: To investigate the curative effect of conservative treatment of ectopic pregnancy with mifepristone and methotrexate. Methods: Eighty patients with ectopic pregnancy who were admitted to our hospital from January 2016 to January 2017 were enrolled in this study. Patients were randomly divided into two groups: control group (n = 40), methotrexate treatment group Forty patients were treated with mifepristone combined with methotrexate, and the treatment effect and adverse reactions were compared between the two groups. Results: The treatment effect was 95.00% in the observation group and 75.00% in the control group. The treatment effect in the observation group was significantly higher than that in the control group (P <0.05), and the incidence of adverse reactions in the observation group was significantly lower than that in the control group The same, are 12.50%, no significant difference between the two groups (P greater than 0.05). Conclusion: Combination of mifepristone and methotrexate can effectively treat ectopic pregnancy, which has some clinical value and is worth popularizing.